Serum free light chain measurement in patients with multiple myeloma and amyloidosis AL

被引：0
|
作者：
Dellerba, MP [1 ]
James, M [1 ]
Butler, SJ [1 ]
Kelsey, PR [1 ]
机构：
[1] Victoria Hosp, Dept Clin Biochem, Blackpool FY3 8NR, England
来源：
CLINICA CHIMICA ACTA | 2005年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [41] Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response
    Moustafa, Muhamad Alhaj
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Buadi, Francis
    Gertz, Morie
    Lacy, Martha
    Kapoor, Prashant
    Hayman, Suzanne
    Dingli, David
    Kyle, Robert
    Kumar, Shaji
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S238 - S238
  • [42] Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio
    Prokaeva, Tatiana
    Spencer, Brian
    Sun, Fangui
    O'Hara, Richard M.
    Seldin, David C.
    Connors, Lawreen H.
    Sanchorawala, Vaishali
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2016, 23 (04): : 214 - 220
  • [43] Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation
    Desikan, KR
    Dhodapkar, MV
    Hough, A
    Waldron, T
    Jagannath, S
    Siegel, D
    Barlogie, B
    Tricot, G
    LEUKEMIA & LYMPHOMA, 1997, 27 (3-4) : 315 - 319
  • [44] Light chain multiple myeloma: when the response will it be evaluated by serum free light chains?
    Corre, Jill
    Avet-Loiseau, Herve
    Hematologie, 2016, 22 (06): : 393 - 394
  • [45] Management of patients with light chain myeloma using serum free light chain immunoassays.
    Bradwell, AR
    Carr-Smith, HD
    Mead, GF
    Harvey, TC
    CLINICAL CHEMISTRY, 2002, 48 (06) : A17 - A18
  • [46] ANALYSIS OF FREE LIGHT CHAINS (FLCS) LEVEL IN PATIENTS (PTS) SUFFERING FROM MULTIPLE MYELOMA (MM) COMPLICATED WITH AMYLOIDOSIS ANTIBODY LIGHT (AL AMYLOIDOSIS)
    Usnarska-Zubkiewicz, L.
    Holojda, J.
    Debski, J.
    Kuliczkowski, K.
    HAEMATOLOGICA, 2012, 97 : 623 - 623
  • [47] Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure
    Chang, Ian C.
    Dispenzieri, Angela
    Scott, Christopher G.
    Lin, Grace
    Jaffe, Allan S.
    Klarich, Kyle W.
    Grogan, Martha
    MAYO CLINIC PROCEEDINGS, 2019, 94 (03) : 447 - 454
  • [48] The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis
    Gatt, Moshe E.
    Kaplan, Batia
    Yogev, Dean
    Slyusarevsky, Elana
    Pogrebijski, Galina
    Golderman, Sizilia
    Kukuy, Olga
    Livneh, Avi
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 86 - 92
  • [49] Splenic rupture secondary to amyloid light-chain (AL) amyloidosis associated with multiple myeloma
    Buzalewski, Jarrod
    Fisher, Matthew
    Rambaran, Ryan
    Lopez, Richard
    JOURNAL OF SURGICAL CASE REPORTS, 2019, (03):
  • [50] Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
    Kyrtsonis, Marie-Christine
    Vassilakopoulos, Theodoros P.
    Kafasi, Nicoletta
    Sachanas, Sotirios
    Tzenou, Tatiana
    Papadogiannis, Argiroula
    Galanis, Zacharoula
    Kalpadakis, Christina
    Dimou, Maria
    Kyriakou, Elias
    Angelopoulou, Maria K.
    Dimopoulou, Maria N.
    Siakantaris, Marina P.
    Dimitriadou, Evangelia M.
    Kokoris, Styliani I.
    Panayiotidis, Panayiotis
    Pangalis, Gerassimos A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (03) : 240 - 243
12345